YUVANCI cpr pell 10 mg/40 mg 30 pce

7680694460026 Pharmacode 1126251 CH-69446 C02KX54 02.07.1.

Active substances:

YUVANCI cpr pell 10 mg/40 mg 30 pce
YUVANCI cpr pell 10 mg/40 mg 30 pce
1 / 2
google

Details

GTIN
7680694460026
Pharmacode
1126251
Product number
6944602
CPT
-
Packaging group
30
Unit
Tablette(n)
Composition
Filmtablette: macitentanum 10 mg, tadalafilum 40 mg, lactosum monohydricum 250.86 mg, cellulosum microcristallinum, carboxymethylamylum natricum A, povidonum K 30, polysorbatum 80, hydroxypropylcellulosum substitutum humile, natrii laurilsulfas, hydroxypropylcellulosum, magnesii stearas, Überzug: hypromellosum, lactosum monohydricum 2.32 mg, triacetinum, talcum, E 171, pro compresso obducto, natrium 2.16 mg.

Articles (1)

Yuvanci 10 mg/40 mg, Filmtabletten
Filmtabletten
30
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
02/10/2026
Professional SmPC
Français
02/10/2026
Professional SmPC
Italien
02/10/2026
Patient information leaflet
Allemand
17/05/2025
Patient information leaflet
Français
17/05/2025
Patient information leaflet
Italien
17/05/2025

Detailed composition

Substance Quantity Type Category
macitentanum
10.0 MG Substance Wirkstoff (Principe actif)
tadalafilum
40.0 MG Substance Wirkstoff (Principe actif)
lactosum monohydricum
250.86 MG Substance HBESI
cellulosum microcristallinum
- Substance HNIDK
carboxymethylamylum natricum A
- Substance HNIDK
povidonum K 30
- Substance HNIDK
polysorbatum 80
- Substance HNIDK
hydroxypropylcellulosum substitutum humile
- Substance HNIDK
natrii laurilsulfas
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
hydroxypropylcellulosum
- Substance HNIDK
magnesii stearas
- Substance HNIDK
hypromellosum
- Substance HNIDK
lactosum monohydricum
2.32 MG Substance HBESI
triacetinum
- Substance HNIDK
talcum
- Substance HNIDK
E 171
- Substance FNIDK
natrium
2.16 MG Substance HBESI

Reimbursement information

Public price
CHF 2781.20
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/03/2025

Authorization holder

Janssen-Cilag AG

6300 Zug

Authorization information

Swissmedic authorization number
69446
Drug name
Yuvanci, Filmtabletten
Galenic form
FILM
ATC Code
C02KX54
Authorization status
Z
Dispensation category
B
First authorization
10/10/2024
Authorization expiration date
09/10/2029
IT number
02.07.1.
Domain
Human medicine
Field of application
Pulmonale arterielle Hypertonie (PAH)

Packaging details

Description (FR)
YUVANCI cpr pell 10 mg/40 mg 30 pce
Description (DE)
YUVANCI Filmtabl 10 mg/40 mg 30 Stk
Market launch
01/03/2025
Narcotic (BTM)
No
Buy us a coffee Explore the data